Share
Mark Headshot

Mom Was Right…

My mother was a nurse. She had a tendency to look at the world two ways: her way and the wrong way. The problem, such as it was, typically turned out to be that her way was the right way. It was both comforting and infuriating all at once. I feel like there are many...
Share

2024 Early Investigator Award Winners Announced

The Endocrine Society is pleased to announce the five early career endocrinologists who have received the 2024 Early Investigator Awards. The Early Investigators Awards were established to help develop early career investigators and recognize their accomplishments in endocrine-related research. Recipients will receive a $1,000 monetary award, complimentary registration and the opportunity to present at ENDO, one-year...
Share

Endocrine Society Advocacy Update – March 2024

Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before...
Share

Bad Reception: Unlocking a Confounding Enigma Behind Monogenic Obesity in Children

When two very different pediatric patients with obesity presented with unusually high leptin levels, endocrine researchers took notice and discovered that leptin was not adequately binding with receptors. When the young patients’ familial history was considered, solutions were finally forthcoming. About three years ago, a 19-month-old girl presented to Sidra Medicine – a women’s and...
Share

ENDO 2024 Highlights

Hammes-ENDO 2022RESIZED With springtime just around the corner (or perhaps still a little further around the corner if you live in Rochester, N.Y., like I do), our thoughts once again turn to sunshine, flowers, and ENDO! This year’s annual meeting in Boston, Massachusetts, June 1-4, promises to be one of our best yet. Members of the dedicated...
Share

Pharma Fridays – March 15

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Topline Results Announced for CAH Studies On March 13, Spruce Biosciences announced topline results from its CAHmelia-203 study of tildacerfont in adult classic congenital adrenal hyperplasia (CAH) and its CAHptain-205 study of tildacerfont in pediatric classic CAH. Spruce is investigating tildacerfont,...
Share

Bariatric Surgery Linked to Cardiovascular Improvements in People with Severe Obesity

Bariatric surgery may result in significant cardiometabolic improvements, particularly among younger, female, or white people and those without comorbidities, according to new research published in the Journal of the Endocrine Society. The United States has the highest obesity rates globally. In 2017 – 2018, about 40% of U.S. adults had obesity and 9% had severe obesity. The prevalence is...